Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Optimization of a Novel DEL Hit That Binds in the Cbl-b SH2 Domain and Blocks Substrate Binding.
Journal: ACS medicinal chemistry letters
Published: February 06, 2024
A carcinoembryonic antigen-specific cell therapy selectively targets tumor cells with HLA loss of heterozygosity in vitro and in vivo.
Journal: Science translational medicine
Published: March 02, 2022
Chimeric Antigen Receptors Directed at Mutant KRAS Exhibit an Inverse Relationship Between Functional Potency and Neoantigen Selectivity.
Journal: Cancer research communications
Published: December 09, 2021
Extensive functional comparisons between chimeric antigen receptors and T cell receptors highlight fundamental similarities.
Journal: Molecular immunology
Published: February 26, 2021
Potent, Selective CARs as Potential T-Cell Therapeutics for HPV-positive Cancers.
Journal: Journal of immunotherapy (Hagerstown, Md. : 1997)
Published: November 28, 2020
Re-examination of MAGE-A3 as a T-cell Therapeutic Target.
Journal: Journal of immunotherapy (Hagerstown, Md. : 1997)
Published: September 24, 2020
HLA-A*02:01-directed chimeric antigen receptor/forkhead box P3-engineered CD4+ T cells adopt a regulatory phenotype and suppress established graft-versus-host disease.
Journal: Cytotherapy
Published: June 19, 2020
Structure-function relationships of chimeric antigen receptors in acute T cell responses to antigen.
Structure-function relationships of chimeric antigen receptors in acute T cell responses to antigen.
Journal: Molecular immunology
Published: June 16, 2020
Showing 1-8 of 8
Last Updated: 09/26/2026